Articles in this Issue
The life sciences industry is right to be optimistic about the potential of generative AI. Biotech startups are already testing AI-generated drugs in clinical trials with human patients. Researchers have estimated that AI-powered ...
read more
Litigation related to pharmaceutical and biotechnological products is not uncommon. The attorney’s fees and costs associated with this litigation are not inexpensive; however, there are ways to mitigate these expenses. One ...
read more
Resolving issues around nitrosamine (NA) contamination has demanded a complex and forensic investigation and the associated regulatory guidance continues to be refined, notably with respect to nitrosamine drug substance-related ...
read more
The concept of continuous improvement is a philosophy of the industry and most pharmaceutical manufacturers as they strive to increase supply, gain efficiencies, and decrease costs and is supported by applicable regulatory ...
read more
Reliance on animal testing for drug development has long been a subject of ethical scrutiny and scientific debate. While the age-old practice contributes much to medical advancement, it raises legitimate concerns about animal ...
read more
Microbiological environmental monitoring (EM) can be complex, generating hundreds or even thousands of sample data points every week. Despite this, many facilities still base their data management on a combination of paper ...
read more
On Thursday 23 November 2023, the PDA Ireland Chapter hosted an event on Microbiology – The Key to Compliance with Annex 1 and Risk Based Regulations. This sold-out event was led by industry leaders, experts, regulators, and ...
read more
Drug discovery and development is a high-risk and costly process requiring specific and sophisticated expertise at every step. Not only is the industry itself becoming more complex, but the products being developed are advancing ...
read more
The impressive abilities of general-purpose chatbots such as ChatGPT and Bard, powered by large language models (LLMs), to generate realistic text has prompted many life science organizations to re-evaluate their approach to ...
read more
The pharma industry continues to be in a state of flux. Merger and acquisition activity remains rife, new regulatory updates are being rolled out all the time, and companies are still reviewing supply chain security following the ...
read more
As the template for all protein synthesis, mRNA serves as the intermediate that allows cells to use genetic information to respond to the dynamicity of life. When applied for therapeutic purposes, mRNA can produce proteins of ...
read more
2023 was a demanding year for Life Sciences manufacturing, with continued pressure to innovate, bring costs down, and overcome very real global supply chain disruption through improved visibility and contingency planning.
read more
The purpose of this column is to highlight and summarize recent key patents in the pharmaceutical arena issued by the US Patent Office in October-November, 2023.
read more
American Motors Corporation was formed in 1954 from the merger of Nash-Kelvinator and the Hudson Motor Car Company. As an automobile manufacturer, they had some success over the years, but always trailed the Big Three – Ford, GM, ...
read more
The Jar provides a robust alternative to the legacy 4-pound (1.8 kg) powdered detergent carton packaging. By garnering feedback from customers, scientists, engineers, lab analysts, and other detergent users, we have created the ...
read more